SequelSEC

Hims & Hers Health, Inc. HIMS

Services-Offices & Clinics of Doctors of Medicine · CIK 0001773751 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$2.35B
Fiscal year ended 2025-12-31
Operating income
$105.61M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Hims & Hers Health, Inc. (HIMS) reported revenue of $2.35B and net income of $128.36M for the fiscal year ended 2025-12-31. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Hims & Hers Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Offices & Clinics of Doctors of Medicine.

Income

Hims & Hers Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue$2.35B$1.48B$872.00M$526.92M$271.88M$148.76M$82.56M
Cost of revenue$614.26M$303.38M$157.05M$118.19M$67.38M$39.31M$37.95M
Gross profit$1.73B$1.17B$714.95M$408.72M$204.49M$109.45M$44.60M
Operating income$105.61M$61.90M-$29.45M-$68.70M-$115.04M-$15.14M-$74.41M
Net income$128.36M$126.04M-$23.55M-$65.68M-$107.66M-$18.11M-$72.06M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 258.23Mshares 236.81Mshares 209.34Mshares 204.52Mshares 186.78Mshares 35.35Mshares 34.76M
Pretax income$123.92M$71.71M-$21.57M-$65.71M-$110.80M-$17.99M-$71.97M
Income tax expense-$4.44M-$54.33M$1.98M-$31.00K-$3.14M$127.00K$90.00K
Diluted EPS$0.51$0.53$-0.11$-0.32$-0.58$-0.51$-2.07
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailable$183.63M$65.60M$55.86M
General & administrative$272.72M$167.77M$129.88M$98.19M$113.66M$26.03MUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Hims & Hers Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Cash & equivalents$228.62M$220.58M$96.66M$46.77M$71.78M$27.34M$1.51M
Total assets$2.15B$707.54M$441.19M$366.34M$420.58M$118.70M$204.77M
Current assets$767.64M$395.83M$265.05M$216.60M$269.90M$113.08M$1.66M
Total liabilities$1.61B$230.82M$97.16M$54.60M$85.97M$15.61M$8.17M
Current liabilities$404.43M$221.37M$88.47M$47.94M$79.22M$15.23M$979.39K
Total equity incl. NCI$540.93M$476.72M$344.03M$311.74M$334.62M-$146.87M-$139.79M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailable$0$249.96M$191.59M
Inventory$80.13M$64.43M$22.46M$21.56M$13.56M$3.54MUnavailable
Accounts receivable$32.15M$6.10M$6.70M$3.90M$4.10M$1.10MUnavailable
Goodwill$278.32M$112.73M$110.88M$110.88M$110.88M$0Unavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$143.28M$91.18M$43.07M$32.36M$19.64M$8.07M$18.48K

Cash flow

Hims & Hers Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Operating cash flow$300.01M$251.08M$73.48M-$26.53M-$34.41M-$2.48M-$74.87M
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow-$1.02B-$19.05M-$12.11M$34.70M-$156.27M-$39.70M-$39.30M
Financing cash flow$729.62M-$107.84M-$11.48M-$33.13M$235.04M$47.74M$95.32M
Net change in cash$7.18M$123.92M$49.89M-$25.01M$44.29M$5.55M-$18.85M
Stock-based compensation$135.24M$92.32M$66.08M$42.82M$67.21M$5.83M$8.03M
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$89.96M$83.04M$2.00M$0$0$0$0
Depreciation & amortization$54.50M$17.09M$9.52M$7.47M$4.08M$1.06M$260.00K

Derived

Hims & Hers Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross margin73.8%79.5%82.0%77.6%75.2%73.6%54.0%
Operating margin4.5%4.2%-3.4%-13.0%-42.3%-10.2%-90.1%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue5.8%6.3%7.6%8.1%24.7%3.9%9.7%
Current ratio1.90x1.79x3.00x4.52x3.41x7.43x1.69x
Revenue YoY growth59.0%69.3%65.5%93.8%82.8%80.2%Unavailable
Net margin5.5%8.5%-2.7%-12.5%-39.6%-12.2%-87.3%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rate-3.6%-75.8%UnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HIMS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-23View SEC filing
10-Q · Filed 2025-11-03View SEC filing
10-Q · Filed 2025-08-04View SEC filing
10-Q · Filed 2025-05-05View SEC filing

Companies in the same industry

AIRS CDIX HLYK LFMD SBC STLN TDOC

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

balance equationreview2019-12-31

Difference 144793009 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.